Status:
WITHDRAWN
Goal Management Training in Individuals With PTSD
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
FDC Foundation
Conditions:
PTSD
Post-traumatic Stress Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study will evaluate the effect of a manualized treatment (Goal Management Training, or GMT) on the cognitive impairments associated with PTSD (Post-Traumatic Stress Disorder), as well as any impa...
Detailed Description
PTSD has an emotional impact on individuals, but it is also associated with impaired cognitive functioning (e.g., processing speed, attention, executive functioning). This study is an effectiveness tr...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- diagnosis of PTSD as determined by our baseline assessment
- Due to online nature: must have access to (and ability to use) a computer/tablet with a working microphone and camera (or webcam), reliable access to a secure internet connection, and access to a quiet, private space for the assessments and group sessions.
- Ability to provide informed consent
- Fluency in written and spoken English
- must be resident of Ontario (due to restrictions of professional licenses)
- Exclusion Criteria for those opting in to fMRI scan:
- any implants, conditions, etc. that do not comply with 7T (Tesla) fMRI research safety standards (e.g., pacemaker, pregnancy/possible pregnancy)
- Exclusion Criteria for study in general:
- history of significant head injury/lengthy loss of consciousness (e.g., a Glasgow Coma Scale Score \< 15 at the time of incident as assessed retrospectively by participant)
- significant untreated medical illness
- history of neurological or neurodevelopmental disorder
- history of any pervasive developmental disorder
- any medical disorder known to adversely affect cognition within the last 12 months
- lifetime bipolar or psychotic disorder
- alcohol/substance abuse or dependence within the last 3 months
- extensive narcotic use (e.g., fentanyl, oxycodone, etc.), use of anti-cholinergics, anti-psychotics, psychostimulants, or benzodiazepines
- ECT (electroconvulsive therapy) within the last 12 months
- significant dissociative disorder (as determined by our baseline assessment)
- suicide attempt in last 6 months
- pregnancy (due to impact of hormones on cognitive abilities)
- hearing or vision issues that would interfere with effective online participation
Exclusion
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04457271
Start Date
January 1 2023
End Date
February 1 2024
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Centre - University Hospital
London, Ontario, Canada, N6A 5A5